comprehensive -WSS

comprehensive

author：explore 2025-09-30 14:09:19 - browse：3155

King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT — Pat Greenhouse/Globe Staff

MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Will the IRA bring competition to the biologics market?

leisure time

WSS

Leqembi, other new Alzheimer’s drugs require better biomarkers

New Covid vaccine is recommended for everyone 6 months or older

FDA proposes changes to key medical devices approval pathway

What to know about OceanGate, the company behind the missing Titanic submersible

New Covid vaccine is recommended for everyone 6 months or older

How medical schools plan to diversify without affirmative action

leisure time

comprehensive

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HCA discloses massive data breach affecting 11 million patients

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Living with Fabry disease, a condition that causes chronic pain

Peter Hotez and the public health issue of online harassment

Bulgari apologizes to China for listing Taiwan as a country after online backlash

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Duchenne breakthrough therapy leaves behind pioneering families

Beach reads and more: STAT's 2023 summer book list

entertainment

New research casts further doubt on a common procedure used with IVF

Generate Biomedicines machine learning biotech raises $273M

Oak trusses raised to roof of fire

A new study sees potential in DNA sequencing of infants

Telehealth for opioid use disorder is lifesaving

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

focus

leisure time

focus

entertainment